Simultaneous microdialysis in brain and blood of the mouse: Extracellular and intracellular brain colchicine disposition

Brain Research

Volumn 786, Issue 1-2, 1998, Pages 122-127

  Evrard, Pierre A ^a   Ragusi, Corinne ^b   Boschi, Gabrielle ^b   Verbeeck, Roger K ^a   Scherrmann, Jean Michel ^b  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b HÔPITAL FERNAND WIDAL   (France)

Author keywords

Blood brain barrier; Colchicine; Microdialysis; Mouse; P glycoprotein; Pharmacokinetics

Indexed keywords

COLCHICINE;

ANIMAL EXPERIMENT; ARTICLE; BLOOD BRAIN BARRIER; DRUG TRANSPORT; HIPPOCAMPUS; MALE; MICRODIALYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; BRAIN; COLCHICINE; EXTRACELLULAR SPACE; HIPPOCAMPUS; INTRACELLULAR FLUID; MALE; MICE; MICE, INBRED STRAINS; MICRODIALYSIS; OSMOLAR CONCENTRATION; TIME FACTORS;

EID: 0008956989     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(97)01454-6     Document Type: Article

References (22)

1. [1] M.J. Barjavel, J.M. Scherrmann, H.N. Bhargava, Relationship between morphine analgesia and cortical extracellular fluid levels of morphine and its metabolites in the rat: a microdialysis study, J. Pharmacol. 116 (1995) 3205-3210.
2. [2] D.J. Begley, D. Lechardeur, Z.D. Chen, C. Rollison, M. Bardoul, F. Roux, D. Scherman, J. Abbott, Functional expression of P-glycoprotein in an immortalised cell line of rat brain endothelial cells, RBE4, J. Neurochem. 67 (1996) 001-008.
3. 3H colchicine into brain and liver of mouse, rat, and chick, Pharmacol. Biochem. Behav. 14 (1981) 863-869.
4. [4] G. Boschi, N. Launay, R. Rips, J.M. Scherrmann, Brain microdialysis in the mouse, J. Pharmacol. Toxicol. Meth. 33 (1995) 29-33.
5. [5] N. Drion, M. Lemaire, J.M. Lefauconnier, J.M. Scherrmann, Role of P-glycoprotein in the blood-brain transport of colchicine and vinblastine, J. Neurochem. 67 (1996) 1688-1693.
6. [6] P.A. Evrard, G. Deridder, R.K. Verbeeck, Intravenous microdialysis in the mouse and the rat: development and pharmacokinetic application of a new probe, Pharm. Res. 13 (1996) 12-17.
7. [7] J.D. Fenstermacher, C.S. Patlak, The movements of water and solutes in the brains of mammals, in: H.M. Pappins, W. Feindel (Eds.), Dynamics of the Brain Edema, Springer, Heidelberg, 1976, pp. 87-97.
8. [8] M. Gibaldi, D. Perrier, Pharmacokinetics, Marcel Dekker, New York, 1982.
9. [9] R.B. Goldschmidt, O. Steward, Preferential neurotoxicity of colchicine for granule cells of the dentate gyrus of the adult rat, Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 3047-3051.
10. [10] R. Kantham, A. Shuaib, G. Goplen, H. Miyashita, A new method of in vivo microdialysis of the human brain, J. Neurosci. Meth. 60 (1995) 151-155.
11. [11] S.S. Matsuyama, L.D. Braun, W.H. Oldendorf, T. Fu, L.F. Jarvik, Colchicine and the blood brain barrier: implications for Alzheimer patients, Age 12 (1989) 107-108.
12. [12] S. Menacherry, W. Hubert, J.B. Justice, In vivo calibration of microdialysis probes for exogenous compounds, Anal. Chem. 64 (1992) 577-583.
13. [13] X. Paez, L. Hernandez, Simultaneous brain and blood microdialysis study with a new removable venous probe. Serotonin and hydroxyindolacetic acid changes after D-norfenfluramine or fluoxetine, Life Sci. 58 (1996) 1209-1221.
14. [14] A. Sabouraud, M. Rochdi, M. Urtizberea, M.O. Christen, G. Achtert, J.M. Scherrmann, Pharmacokinetics of colchicine: a review of experimental and clinical data, Z. Gastroenterol. 30 (1992) 35-39.
15. [15] Y. Sato, S. Shibanoki, M. Sagahara, K. Ishikawa, Measurement and pharmacokinetic analysis of imipramine and its metabolites by brain microdialysis, Br. J. Pharmacol. 112 (1994) 625-629.
16. [16] J.M. Scherrmann, L. Boudet, R. Pontikis, N. Nguyen-Huang, E. Fournier, A sensitive radioimmunoassay for colchicine, J. Pharm. Pharmacol. 32 (1980) 800-802.
17. [17] A.M. Schinkel, J.J.M. Smith, O. van Tellingen, J.H. Beijnen, E. Wagenaar, L. van Deemter, Mol CAAM, M.A. van der Valk, E.G. Robanus-Maandag, H.P.J. Riele, A.J.M. Berns, P. Borst, Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs, Cell 77 (1994) 491-502.
18. [18] L. Stahle, B. Oberg, Pharmacokinetics and distribution over the blood-brain barrier of two acyclic guanosine analogs in rats, studied by microdialysis, Antimicrob. Agents Chemother. 36 (1992) 339-342.
19. [19] F. Stain, M.J. Barjavel, P. Sandouk, M. Plotkine, J.M. Scherrmann, H.N. Bhargava, Analgesic response and plasma and brain extracellular fluid pharmacokinetics of morphine and morphine-6-β-D-glucuronide, J. Pharmacol. Exp. Ther. 274 (1995) 852-857.
20. [20] I. Szentistvanyi, C.S. Patlak, R.A. Ellis, H.F. Cserr, Drainage of interstitial fluid from different regions of rat brain, Am. J. Physiol. 246 (1984) F835-F844.
21. [21] Y. Wang, D.F. Welty, The simultaneous estimation of the influx and efflux blood-brain barrier permeabilities of gabapentin using a microdialysis-pharmacokinetic approach, Pharm. Res. 13 (1996) 398-403.
22. 3H]colchicine in brain and spinal cord areas following its intracerebroventricular or intra-spinal cord injection in rats, Drug Metab. Dispos. 16 (1988) 473-476.